Kypha, Inc.

Calculating rank

USPTO Granted Patents = 5

EPO Patents = 2

Trademarks = 3

Forward Citations = 7

Loading Chart...

4 inventors (with patents filed for the assignee):

Paul Olson (5 out of 24 patents)

Don W Moss (4 out of 4 patents)

Nicholas Staten (3 out of 3 patents)

4. Alfred Kim (1 out of 1 patent)

5. Donald W Moss (0 patent)

6. Nick Staten (0 patent)

7. Donald Moss (0 patent)

5 patents: Sort by Forward Citations

1. 11029318 - Methods for predicting and treating patients with increased risk of adverse pregnancy outcome (2021-06-08),

2. 9939446 - Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders (2018-04-10),

3. 9182396 - Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders (2015-11-10),

4. 9164088 - Detecting complement activation (2015-10-20),

5. 8865164 - Detecting complement activation (2014-10-21),

Company Overview

Kypha, Inc. is a biotechnology company focused on developing innovative immune diagnostic products for inflammatory diseases. Their solutions help clinicians make more informed treatment decisions and improve patient outcomes. With a strong commitment to research and development, Kypha is dedicated to advancing the field of immune diagnostics.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#292 in St. Louis, MO

#729 in Missouri

#51,669 in US

St. Louis, MO, United States of America

Kypha, Inc.

Forward Citations = 7

4 inventors:

Paul Olson (5 out of 24 patents)

Don W Moss (4 out of 4 patents)

Nicholas Staten (3 out of 3 patents)

4. Alfred Kim (1 out of 1 patent)

5. Donald W Moss (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kypha, Inc.. Retrieved from https://idiyas.com/company/kypha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]